Your Best Shot at Surviving the Flu Season by Liu, Isabella
BU Well 
Volume 5 Health, Wellness, and Life Sciences Clinical Corner 
2020 
Your Best Shot at Surviving the Flu Season 
Isabella Liu 
Butler University 
Follow this and additional works at: https://digitalcommons.butler.edu/buwell 
 Part of the Virus Diseases Commons 
Recommended Citation 
Liu I. Your Best Shot at Surviving the Flu Season. BU Well. 2020; 5(1). 
This Clinical Corner is brought to you for free and open access by the Undergraduate Scholarship at Digital 
Commons @ Butler University. It has been accepted for inclusion in BU Well by an authorized editor of Digital 
Commons @ Butler University. For more information, please contact digitalscholarship@butler.edu. 
Your Best Shot at Surviving the Flu Season 
Isabella Liu 
Abstract: Millions of individuals become ill from the influenza virus every year.  As an existing public health issue, it is important for patients to understand 
that the best way to combat the influenza virus is through prevention. This article explores key aspects of the influenza vaccine and highlights its importance 
in the healthcare community. 
he Centers for Disease Control and Prevention estimates that
about 49 million individuals in the United States were ill with
the influenza virus during the 2017-2018 influenza 
season.1 Influenza viruses A and B are mostly responsible for 
causing seasonal influenza outbreaks.2 In addition to seasonal 
illness, the influenza virus can often cause secondary 
complications, hospitalizations, and deaths. The first reliable 
documented record of an influenza-like disease dates back to the 
year 1510. In the centuries following, multiple influenza epidemics 
occurred, affecting many different continents.3 An example of a 
widespread epidemic was the “Spanish” influenza pandemic of 
1918. It was one of the deadliest outbreaks, affecting about one-
third of the global population and caused an estimated 21 million 
deaths.4 However, a breakthrough in the treatment of influenza 
occurred in 1938 when Jonas Salk and Thomas Francis developed 
the first influenza vaccine.3 The influenza vaccine is still the best 
protection currently available against the influenza virus. 
Seasonal outbreaks of the influenza virus cause millions of 
individuals to fall ill. This respiratory virus is extremely contagious 
and can infect the nose, throat, and lungs. Symptoms include 
coughing and disruption of the upper respiratory tract, fever, 
muscle aches, headaches, and fatigue.5 Transmission of the 
influenza virus can be grouped into two categories: acquisition by 
large droplets and acquisition by smaller, aerosol particles. Both 
large droplets and small particles may be transmitted through 
contact with particles from affected individuals who cough or 
sneeze. Transmission by small aerosol particles tends to be longer 
reaching since these particles are lightweight and can travel longer 
distances, while acquisition of the illness by large droplets is 
limited to close interactions.6  
Once infected by the influenza virus, the average incubation period 
is 2 days. Individuals with influenza are most contagious during the 
first 3 and 4 days of getting sick.5  However, individuals with the 
influenza virus can spread it 24 hours before the onset of 
symptoms up to 5-7 days of having the illness. Most otherwise 
healthy individuals are symptomatic for 5-7 days.5 In the case of 
special populations, such as children and/or immunocompromised 
individuals, symptoms can last longer than the typical time frame. 
Consequently, such individuals will continue to be contagious as 
the illness persists.5 Ultimately, the influenza virus’s rapid 
transmission from person to person leads to widespread outbreaks 
during the influenza season.   
The antigenic composition of the influenza virus plays a large role 
in the virus’s ability to infect humans and animals. There are four 
different types of influenza viruses, which include: A, B, C, and D. 
Influenza viruses A and B are most likely to cause annual, 
seasonal outbreaks, with influenza virus A being most known for 
drastically morphing and causing pandemics. Additionally, 
influenza virus C is generally mild while influenza virus D is 
prominent in cattle.7 Virus composition includes two main 
surface glycoproteins that are called hemagglutinin and 
neuraminidase. Changes in these glycoproteins are responsible 
for changes in annual influenza season outbreaks and can cause 
pandemics. The first type of change is called antigenic drift which 
occurs when there are small mutations in the surface 
glycoproteins. These small changes are the reason why different 
strains are responsible for each influenza season. The second 
type of change, which is called antigenic shift, is a major and 
abrupt change in the glycoproteins which results in 
pandemics. Antigenic shift most commonly occurs with influenza 
virus A. The most recent pandemic caused by antigenic shift in 
the United States was in 2009 with the H1N1 emergence.8 
Today, the influenza vaccine is the best chance at preventing 
influenza contraction and lessening the severity of the illness if 
an individual does become infected.5 Vaccines are generally 
administered via injection or nasal spray. The nasal spray 
contains the live attenuated version of the virus while the 
injection is inactivated. Both types cause an immune response to 
the disease, in which the body produces antibodies and develops 
immunity, making it less likely to contract 
influenza. Furthermore, if a vaccinated person does become ill, 
they already have antibodies from the vaccine exposure that 
allow the body to fight the disease more effectively.9 It is 
important to note that the influenza season begins in the fall of 
one year and continues into the spring of the following year. The 
influenza vaccination should be received in the beginning of the 
influenza season for maximum effectiveness, since it takes 
around two weeks after administration for antibodies to 
develop.5  
As discussed earlier, the influenza virus mutates at a quick 
rate.  Therefore, new influenza vaccinations are created for every 
influenza season. New vaccinations are necessary to target new 
variations in the influenza virus. Experts create the influenza 
vaccine about six months prior to the start of the influenza 
season. They determine which strains the influenza vaccine 
should encompass based on global data from the previous 
influenza season. Trivalent and quadrivalent influenza 
vaccinations are offered. The trivalent vaccine is composed of 
two strains of virus A antigens and one strain of virus B antigens. 
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Similarly, the quadrivalent vaccine is composed of two strains of 
virus A antigens but also contains two strains of virus B antigens.2 
After experts predict the more common strains for the upcoming 
season, the World Health Organization releases information 
annually on their website regarding the current vaccines, including 
the specific strains. 
 
It is important to understand the indications and possible 
exceptions to the influenza vaccination. Individuals including 
children older than 6 months, healthy adults, the elderly, and those 
immunocompromised should receive the influenza vaccine every 
year.2  Children up to age 8 who have not previously received the 
influenza vaccine need 2 doses, given 4 weeks apart. Children who 
have previously received the influenza vaccine can receive one, 
single dose.2  It is important to note that children and individuals 
65 years and older are most susceptible to contracting influenza. 
Those who are 65 years and older have the largest disease burden, 
with an estimated 70% to 85% of deaths and 50% to 70% of 
hospitalizations due to influenza. There are two types of 
inactivated vaccine injections specifically approved for this 
population, the High Dose Flu Vaccine and Adjuvanted Flu Vaccine. 
Both invoke a greater immune response compared to the other 
influenza vaccines. The High Dose Flu Vaccine contains four times 
the antigen of a single dose while the Adjuvanted Flu Vaccine 
contains an additive that creates a stronger immune response. 
Aluminum salts or oil in water emulsions are the ingredients often 
added to the Adjuvanted Flu Vaccine.10  
 
In regard to expecting mothers, the Centers for Disease Control 
and Prevention emphasizes that it is safe for pregnant women to 
get the influenza vaccine. Not only will the vaccine protect the 
mother, but the mother will pass on the antibodies created by her 
immune system to the baby.  As far as immunocompromised 
individuals, the Advisory Committee on Immunization Practices 
(ACIP) recognizes that the immunogenicity of influenza is lower in 
this patient population. However, the vaccine will still significantly 
protect immunocompromised individuals against the virus. It is 
recommended that they receive the inactivated injection, not the 
attenuated live nasal vaccine.2 Other people who should avoid the 
nasal spray vaccine include caregivers of or those in close contact 
with immunocompromised individuals, pregnant women, children 
less than 2 years old, children 2-17 years old who are also taking 
aspirin, children 2-4 years old with asthma, or adults 50 years and 
older.5 These individuals should receive the inactivated injection 
instead. Individuals with egg allergies can receive the vaccine as 
well. Those with a history of a severe allergic reaction to eggs with 
symptoms other than hives should receive the vaccine in an 
inpatient or outpatient medical setting, under the supervision of a 
licensed medical professional who can take further action if 
necessary. However, if the individual previously had an allergic 
reaction to the influenza vaccine, future egg-based vaccines are 
contraindicated.11 Cell-based flu vaccines are available as an 
alternative because it is not created with eggs.11 
 
Overall, the influenza vaccine has proven to lessen the influenza 
burden of the world’s population. According to the World Health 
Organization, annual influenza epidemics affect 3 to 5 million 
people globally.13 The Centers for Disease Control and Prevention 
measures the effect of influenza on the U.S. population by looking 
at cases of influenza-related medical visits, hospitalizations, and 
deaths. In the 2017-2018 influenza season, the U.S. had an 
estimated 49 million people who were symptomatic, 23 million 
people who scheduled a medical visit, 960,000 people who were 
hospitalized, and 79,000 people who died from the influenza 
virus.1 Due to the widespread impact of the influenza virus, it is 
important for individuals to receive the influenza vaccination 
annually. Not only does the vaccine decrease a person’s odds of 
becoming ill with influenza, but it also helps decrease the severity 
of the disease. This may be crucial in highly susceptible 
populations such as children, immunocompromised individuals, 
and the elderly.  Ultimately, it is the responsibility of all 
healthcare providers to educate patients on the severity of the 
seasonal influenza and to advocate for individuals to get their 
influenza vaccine.  
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